Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement
On April 29, 2026, a rare-disease deal reshapes biotech M&A expectations as investors weigh tender terms.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for RARE skewed neutral (28 of 46 scored calls).
AI-curated news influencing RARE price, sentiment, and trend
On April 29, 2026, a rare-disease deal reshapes biotech M&A expectations as investors weigh tender terms.
A fully-laden Japan-linked oil tanker completed a rare transit of the Strait of Hormuz, as the effective closure of the …
Chiesi Farmaceutici SpA agreed to acquire US-listed KalVista Pharmaceuticals Inc. for about $1.9 billion in its biggest acquisition to date, …
(Bloomberg) -- Key congressional Republicans are poised to break with Donald Trump on his proposed 44% raise for the Pentagon, …
Uzbekistan’s national investment fund’s initial public offering is set to value the vehicle at about $1.95 billion, as it offers …
Shares in China’s major rare earths producers advanced after the government unveiled detailed penalties for unauthorized production, marking a fresh …
Multi-Provider AI Analysis